Skip to content
DAT Supply Log in
Gummies

Vitamin B3 (Niacin / Nicotinamide)

INCI: Nicotinamide

Nicotinamide, also known as niacinamide, is a water-soluble form of vitamin B3 used in food supplements. It is one of the most familiar and commercially understood gummy actives across EU and US markets. Under EU Regulation 432/2012, niacin (including nicotinamide) carries authorised claims for normal energy-yielding metabolism, nervous system function, psychological function, maintenance of normal skin, reduction of tiredness and fatigue, and normal mucous membranes.

  • Energy metabolism
  • Skin health
  • Nervous system
Build a formula with this ingredient
Vitamin B3 (Niacin / Nicotinamide)

At a glance

Definition
Nicotinamide, also known as niacinamide, is a water-soluble form of vitamin B3 used in food supplements. It is one of the most familiar and commercially understood gummy actives across EU and US markets. Under EU Regulation 432/2012, niacin (including nicotinamide) carries authorised claims for normal energy-yielding metabolism, nervous system function, psychological function, maintenance of normal skin, reduction of tiredness and fatigue, and normal mucous membranes.
Authorised wording (summary)
6 authorised statements — see "EU-authorised health claims" below.
Common positionings
  • Energy and vitality
  • Beauty nutricosmetics
  • Daily wellness
  • Healthy ageing
  • Skin health support
Format suitability
Reviewed for gummies and sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Positioning

What it is

Nicotinamide is the amide form of niacin (vitamin B3), a water-soluble vitamin essential for cellular energy production and DNA repair. Unlike nicotinic acid, nicotinamide does not cause the flushing reaction at typical supplement doses, making it the preferred form for oral supplements including gummies.

Brands use nicotinamide in gummy formulations because it is heat-stable, soluble, and neutral-tasting at supplement doses. It supports a wide range of positioning angles from energy and vitality to beauty nutricosmetics and healthy ageing, backed by a robust set of EFSA-authorised health claims.

Origin and history

Nicotinamide was first identified in the 1930s as the anti-pellagra factor in the vitamin B complex. Pellagra, a disease caused by niacin deficiency, was widespread in populations subsisting on maize-based diets. The isolation and synthesis of nicotinamide revolutionised public health nutrition.

Today, nicotinamide is produced industrially through chemical synthesis from 3-picoline or via hydrolysis of nicotinonitrile. It is manufactured as a white crystalline powder with high purity and stability, suitable for direct incorporation into gummy and sachet formulations.

Scientific overview

Nicotinamide functions as a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme central to cellular energy metabolism. NAD+ is required for redox reactions in glycolysis, the citric acid cycle, and oxidative phosphorylation. Adequate niacin status therefore supports normal energy-yielding metabolism and the reduction of tiredness and fatigue.

Bioavailability of nicotinamide from oral supplements is high, with rapid absorption in the small intestine. Unlike nicotinic acid, nicotinamide does not bind to the GPR109A receptor, which is responsible for the prostaglandin-mediated flushing reaction. This makes nicotinamide the preferred form for sustained supplementation at doses up to 900 mg per day.

From a manufacturing perspective, nicotinamide is heat-stable and water-soluble, with no known incompatibilities with common gummy excipients. It has a neutral taste profile at supplement doses, requiring no masking. The cost-per-mg is low, making it an economical active for mass-market formulations.

Why brands use Vitamin B3 (Niacin / Nicotinamide)

Nicotinamide is one of the most familiar and commercially understood gummy actives across EU and US markets. It supports multiple positioning angles including energy and vitality, beauty nutricosmetics (skin health), daily wellness, and healthy ageing. The EFSA-authorised claims for normal energy-yielding metabolism, nervous system function, and maintenance of normal skin provide strong, compliant pack-copy hooks.

From a formulation and manufacturing perspective, nicotinamide is straightforward to work with. It is heat-stable, soluble in gummy matrices, and neutral-tasting at supplement doses. The low cost-per-mg allows for flexible dosing from NRV levels (16 mg) up to higher levels for specific positioning. DAT confirms final formulation parameters per project.

For pack copy, brands can use any of the EFSA-authorised claims verbatim. No disease claims are permitted. Certification promises (vegan, kosher, halal, non-GMO, organic) depend on the selected raw material and supplier documentation. DAT confirms certification status per project and batch before final label claims. Shelf-life claims are confirmed per project with stability data.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Low

Forms available

  • Nicotinamide (pure crystalline powder)

Dosage reference

EU NRV for niacin is 16 mg. Brand positioning typically ranges from 16 mg to 50 mg per serving. Higher doses (up to 900 mg) are used in some formulations but require careful regulatory review per market.

Taste & sensory

Neutral to mild taste at supplement doses.

Manufacturing notes

No specific formulation notes. Standard processing applies.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

  • Taste masking and aroma load against the cooked-base flavour — confirmed per project.
  • Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
  • Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
  • Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

EU-authorised health claims

  • Niacin contributes to normal energy-yielding metabolism.Reg. (EU) 432/2012
  • Niacin contributes to normal functioning of the nervous system.Reg. (EU) 432/2012
  • Niacin contributes to normal psychological function.Reg. (EU) 432/2012
  • Niacin contributes to the maintenance of normal skin.Reg. (EU) 432/2012
  • Niacin contributes to the reduction of tiredness and fatigue.Reg. (EU) 432/2012
  • Niacin contributes to normal mucous membranes.Reg. (EU) 432/2012

Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.

Nicotinamide is an authorised form of niacin under EU food supplements law. All claims above are EFSA-authorised verbatim under Reg. (EU) 432/2012. The ingredient is listed in Annex II of Reg. (EC) 1925/2006.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)·EFSA Journal·2009

  2. Bogan KL, Brenner C·Trends in Biochemical Sciences·2008

  3. Kirkland JB·Nutrients·2020

  4. Knip M, Douek IF, Moore WP, et al.·European Journal of Clinical Nutrition·2000

  5. European Commission·Official Journal of the European Union·2012

Catalogue match

Product concepts featuring Vitamin B3 (Niacin / Nicotinamide)

Private-label product concepts where Vitamin B3 (Niacin / Nicotinamide) appears in the formula. Each opens to a product brief and quote route.

Synergies & conflicts

Pairs well with

Synergy data needs review.

Care when combining with

Conflict data needs review.

Adjacent reading

Pairings, resource guides and blog notes most often associated with Vitamin B3 (Niacin / Nicotinamide) on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with Vitamin B3 (Niacin / Nicotinamide).

Project handoff

Develop a formula featuring Vitamin B3 (Niacin / Nicotinamide)

A ready white-label formula exists — open a product brief, or talk to our team to align the launch plan.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.